These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20884641)

  • 1. Controlling cardiomyocyte length: the role of renin and PPAR-{gamma}.
    Hinrichs S; Heger J; Schreckenberg R; Wenzel S; Euler G; Arens C; Bader M; Rosenkranz S; Caglayan E; Schlüter KD
    Cardiovasc Res; 2011 Feb; 89(2):344-52. PubMed ID: 20884641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.
    Duan SZ; Ivashchenko CY; Russell MW; Milstone DS; Mortensen RM
    Circ Res; 2005 Aug; 97(4):372-9. PubMed ID: 16051889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
    Chen Y; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y; Qian J
    Diab Vasc Dis Res; 2017 Mar; 14(2):152-162. PubMed ID: 28111985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor-alpha decreases endothelin-1-induced p38 mitogen-activated protein kinase activation in cardiomyocytes.
    Irukayama-Tomobe Y; Miyauchi T; Kasuya Y; Sakai S; Goto K; Yamaguchi I
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S358-61. PubMed ID: 15838320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
    Birnbaum Y; Long B; Qian J; Perez-Polo JR; Ye Y
    Basic Res Cardiol; 2011 May; 106(3):431-46. PubMed ID: 21360043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of central PPAR-γ attenuates angiotensin II-induced hypertension.
    Yu Y; Xue BJ; Wei SG; Zhang ZH; Beltz TG; Guo F; Johnson AK; Felder RB
    Hypertension; 2015 Aug; 66(2):403-11. PubMed ID: 26101342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prorenin induces intracellular signaling in cardiomyocytes independently of angiotensin II.
    Saris JJ; 't Hoen PA; Garrelds IM; Dekkers DH; den Dunnen JT; Lamers JM; Jan Danser AH
    Hypertension; 2006 Oct; 48(4):564-71. PubMed ID: 16940215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes.
    Wenzel S; Rohde C; Wingerning S; Roth J; Kojda G; Schlüter KD
    Hypertension; 2007 Jan; 49(1):193-200. PubMed ID: 17075027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.
    Choukroun G; Hajjar R; Kyriakis JM; Bonventre JV; Rosenzweig A; Force T
    J Clin Invest; 1998 Oct; 102(7):1311-20. PubMed ID: 9769323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages.
    Neri T; Cordazzo C; Carmazzi Y; Petrini S; Balìa C; Stefanelli F; Amoruso A; Brunelleschi S; Breschi MC; Pedrinelli R; Paggiaro P; Celi A
    Cardiovasc Res; 2012 Jun; 94(3):537-44. PubMed ID: 22425902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.
    Caglayan E; Stauber B; Collins AR; Lyon CJ; Yin F; Liu J; Rosenkranz S; Erdmann E; Peterson LE; Ross RS; Tangirala RK; Hsueh WA
    Diabetes; 2008 Sep; 57(9):2470-9. PubMed ID: 18511847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone induces interleukin-18 through endothelin-1, angiotensin II, Rho/Rho-kinase, and PPARs in cardiomyocytes.
    Doi T; Sakoda T; Akagami T; Naka T; Mori Y; Tsujino T; Masuyama T; Ohyanagi M
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1279-H1287. PubMed ID: 18660453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
    He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated linoleic acid prevents high glucose-induced hypertrophy and contractile dysfunction in adult rat cardiomyocytes.
    Aloud BM; Raj P; O'Hara K; Shao Z; Yu L; Anderson HD; Netticadan T
    Nutr Res; 2016 Feb; 36(2):134-42. PubMed ID: 26826429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice.
    Barbieri M; Di Filippo C; Esposito A; Marfella R; Rizzo MR; D'Amico M; Ferraraccio F; Di Ronza C; Duan SZ; Mortensen RM; Rossi F; Paolisso G
    PLoS One; 2012; 7(4):e35999. PubMed ID: 22563432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
    Chana RS; Lewington AJ; Brunskill NJ
    Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of calcium homeostasis by cardiac-specific over-expression of PPAR-γ in mice: A role in ventricular arrhythmia.
    Xie Y; Gu ZJ; Wu MX; Huang TC; Ou JS; Ni HS; Lin MH; Yuan WL; Wang JF; Chen YX
    Life Sci; 2016 Dec; 167():12-21. PubMed ID: 27746188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
    Ye P; Yang W; Wu SM; Sheng L
    Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):691-6. PubMed ID: 17235413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.